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MaterIals and Methods
The multilayer-film analytical element for glucose consists of a spreading layer, a blocking layer, an enzymic reagent layer, and a transparent support. The spreading layer is a finely woven thin web having an active surface over which blood spreads quickly and uniformly after spotting. Blood cells and platelets are filtered off through the fibrous structure of the spreading layer, but plasma diffuses through to the blocking layer. Diffusion of macromolecules and hydrophobic substances bound to proteins in plasma is blocked at the blocking layer and thus they do not reach the reagent layer. The spreading layer also serves to avoid ringing or chromatographic phenomena and thus helps to yield good results.
The blocking layer not only blocks macromolecular constituents, but also serves as a reflector for reflection densitometry and a shield from interference by colored materials in blood such as hemoglobin and bilirubin on the spreading layer.
In the reagent layer, glucose oxidase (EC 1.1.3.4), peroxidase (EC 1.11.1.7), and color-developing reagents are incorporated Time (mm)
Glucose concentration(mg/L)
as a solid phase. The color develops in the series of reactions reported by Trinder (2) : the oxidation of glucose is catalyzed by glucose oxidase followed by an oxidative coupling catalyzed by peroxidase.
(00)
The incubator-photometer equipment and film elements were made by Fuji Photo Film Co.
The procedure for determining plasma glucose concentrations in whole-blood samples with this equipment is as follows:
#{149} insert a film element into the equipment #{149} apply a spot of whole blood onto the element with a 10-ML Hamilton syringe (The following steps proceed automatically) #{149} incubate at 37 #{176}C for 6 mm to develop the color #{149} measure color density by reflection at 500 nm, through the support #{149} convert the reflection density into plasma glucose concentration, based on the predetermined calibration curve which is in memory of a microcomputer incorporated in the equipment #{149} print out the result The equipment is checked with a reference film, a piece of photographic silver halide paper, once a day to ascertain whether or not the photometry is working well. Figure 1 illustrates the development of reflection density at 500 nm as a result of the reaction after whole-blood samples are spotted. Development of color is nearly complete in 6 mm, except at the highest concentration, but this is followed by a slow, continuing reaction. We routinely measured reflection density at 6 mm after spotting a drop of sample on the film, except as otherwise described.
Results

Quantitation of the Dye Reaction
The Calibration Curve
The calibration curve for plasma glucose was determined with glucose-supplemented whole-blood samples supplied by the manufacturer (Figure 2 ) and put into the memory of the microcomputer that is part of the equipment. Users of this equipment need not themselves determine calibration curves.
They only need check the system with a reference film and a glucose solution of known glucose concentration. shows that blood glucose concentrations that exceed 7 g/L can be determined by 12-mm instead of 6-mm incubation.
Properties of the Spreading Layer
With various volumes of the same sample from 7 through 11 iiL we obtained the same mean calculated value, 109 (SD 2.8) mg/dL, by the present method. With a sample volume larger than 11 giL, the identical value was also obtained if we used an element with a wider well. Evidently the errors found with a sample volume of more than 11 tL are accounted for by overflood of the sample solution in the well of the element. Blood specimens with various hematocrit values, prepared by centrifugation from a blood sample treated with NaF and heparin, gave essentially the same values over a 10-50% hematocrit range (Figure 3 ).
Some Analytical Variables
Precision.
Within-run reproducibility was studied with NaF-and heparin-treated blood samples having different glucose concentrations ( Table 1 ). The coefficients of variation (CV) were all <2.5%. Because whole-blood samples are unstable, we used sera for the between-run reproducibility study. For determination of serum samples, however, we used another type of element with a different spreading layer (3), which had been developed for determination of glucose concentrations in serum or plasma. Consequently, the whole analytical system except for the property of the spreading layer of the element was evaluated in the between-run study. Errors in measurements of sera were smaller than those on whole blood. Three serum samples with different glucose concentrations were measured twice daily for 11 successive days (21 runs altogether).
The result shown for each run represents the mean of duplicate determinations ( Table 1) . The CV's were all <2%. To determine the minimum concentration of glucose that could be detected by this method, we prepared blood samples with low glucose concentrations from aged heparmnized blood. Serum samples with low glucose concentrations were obtained by dialyzing serum against a pH 7.4 phosphate buffer. The minimum detectable glucose concentration was 100 mg/L.
Hct (%)
Fig
Analytical recovery.
A whole-blood sample treated with NaF and heparin was analyzed five times for glucose with our analytical system. Glucose was weighed into 5-mL aliquota of the sample. After mixing and being allowed to stand for 2 hat 5#{176}C, each solution was analyzed five times by our method. Plasma was obtained from these samples by centrifugation and the glucose concentrations were determined by the hexokinase method. The mean values for glucose concentrations by our method were within 94-106% of those by the hexokinase method (Table 2) .
Interference.
Interference was studied with use of the elements developed for glucose determination in plasma or serum. Neither hemoglobin (40-5000 mg/L), triglyceride (40-18000 mg/L), nor bilirubin (2-5000 mg/L) interfered with the determination of glucose, because of the filtering action of the blocking layer. Samples with protein concentrations >90 g/L gave values for apparent glucose that were 5% high or more. Table 3 shows the results of our study of exogenous interfering materials.
Stability of the film element.
Storage of film elements at 4 #{176}C for a year in their packages did not affect their performance.
Comparison of Methods
We compared results by the present method with those by the hexokinase method. The coefficient of correlation between the two methods was 0.989 (n = 160). The regression line was y = 0.97x + 4.85 = 5.9), where y represents results by the present method and x those by the hexokinase method. Sample concentrations covered the range 0.8-6.0 g/L.
Discussion
The present method shows similar performance to that of the "Ektachem" in glucose analysis, but in this method whole blood can be used for glucose analysis. The hematocrit of the applied samples slightly affected the spreading action of the spreading layer and thus interfered with the measurement, as shown in Table 1 . On this account, we developed another type of element with a different spreading layer for determination of plasma or serum glucose concentrations (3) . An interference study with dysproteinemic serum samples also revealed errors in measurement due to variation in viscosity of samples, but such errors were usually negligible for clinical evaluation of blood glucose.
When the volume of a sample was less than 7 iiL, the area of the color developed in the element was inappropriately small for densitometry, and the apparent value obtained was lower than the correct one. On the other hand, when the amount of a sample was more than 11 giL, the sample solution flooded the well of the element, and the apparent value was larger than the correct one. Consequently, the appropriate amount of sample for the element is 7-11 itL. Within this volume range, the amount of a sample spotted on the film need not be measured precisely to obtain a good result. This property, associated with the advantage of this method that whole blood can be used for glucose analysis, may make this method suited for use in ambulance and clinical office.
We are trying to improve the performances of both the film elements and the incubator-densitometer apparatus, especially with respect to reducing the error due to viscosity of the samples, widening the range of measurable glucose concentrations, and making the apparatus compact. Random, systemic and total errors of measurement of this system in clinical laboratories are under investigation.
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